LSE - Delayed Quote GBp

International Biotechnology Ord (IBT.L)

Compare
686.00 -6.00 (-0.87%)
As of 4:01:45 PM GMT. Market Open.
Advanced Chart
Loading Chart for IBT.L
DELL
  • Previous Close 692.00
  • Open 697.00
  • Bid 686.00 x --
  • Ask 688.00 x --
  • Day's Range 686.00 - 700.00
  • 52 Week Range 596.00 - 802.84
  • Volume 58,910
  • Avg. Volume 92,538
  • Market Cap (intraday) 247.429M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 6.73
  • EPS (TTM) --
  • Earnings Date Nov 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: IBT.L

View More
View More

Performance Overview: IBT.L

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

IBT.L
0.29%
FTSE 100
1.59%

1-Year Return

IBT.L
7.54%
FTSE 100
7.37%

3-Year Return

IBT.L
11.68%
FTSE 100
10.22%

5-Year Return

IBT.L
35.92%
FTSE 100
8.58%

Compare To: IBT.L

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

IBT.L
International Biotechnology Ord
686.00
-0.87%
Mkt Cap GBp 247.429M
Industry Biotechnology
9PT.F
Pliant Therapeutics Inc
11.90
-0.83%
Mkt Cap EUR -
Industry Biotechnology
SCLP.L
Scancell Holdings plc
9.86
+1.13%
Mkt Cap GBp 103.276M
Industry Biotechnology
ONT.L
Oxford Nanopore Technologies plc
131.20
-1.58%
Mkt Cap GBp 1.253B
Industry Biotechnology
HVO.L
hVIVO plc
18.01
-1.04%
Mkt Cap GBp 123.545M
Industry Biotechnology
OKUR
OnKure Therapeutics, Inc.
7.44
-4.73%
Mkt Cap 99.248M
Industry Biotechnology
SPRB
Spruce Biosciences, Inc.
0.3753
-1.24%
Mkt Cap 15.501M
Industry Biotechnology
POLB.L
Poolbeg Pharma PLC
5.30
-5.36%
Mkt Cap GBp 26.5M
Industry Biotechnology
RNXT
RenovoRx, Inc.
1.3410
+1.59%
Mkt Cap 32.186M
Industry Biotechnology
XLO
Xilio Therapeutics, Inc.
1.0600
-5.36%
Mkt Cap 48.461M
Industry Biotechnology
RLMD
Relmada Therapeutics, Inc.
0.4375
-3.21%
Mkt Cap 13.201M
Industry Biotechnology

Statistics: IBT.L

View More

Valuation Measures

As of 1/9/2025

  • Market Cap

    249.18M

  • Enterprise Value

    --

  • Trailing P/E

    6.80

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.58

  • Price/Book (mrq)

    0.88

  • Enterprise Value/Revenue

    6.78

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: IBT.L

View More
View More

People Also Watch

BIOG.L Biotech Growth Ord
837.00
-1.65%
 
WWH.L Worldwide Healthcare Ord
322.00
-0.62%
 
FGT.L Finsbury Growth & Income Ord
895.00
-1.21%
 
PCT.L Polar Capital Technology Ord
349.00
-1.13%
 
HSL.L Henderson Smaller Companies Ord
763.86
-1.44%
 
BRWM.L BlackRock World Mining Trust Ord
485.10
+0.02%
 
ATT.L Allianz Technology Trust Ord
415.00
-1.43%
 
HRI.L Herald Ord
2,502.78
-0.09%
 
EWI.L Edinburgh Worldwide Ord
194.99
-0.01%
 
BGS.L Baillie Gifford Shin Nippon Ord
112.00
-0.53%
 
HFEL.L Henderson Far East Income Ord
230.00
-0.86%
 
EAT.L European Assets Ord
81.72
-0.34%
 
TRY.L TR Property Ord
291.64
-1.47%
 
EGL.L Ecofin Global Utilities & Infra Ord
179.59
-2.13%
 
MYI.L Murray International Ord
253.50
-0.98%
 
MNKS.L Monks Ord
1,254.00
-0.95%